<DOC>
	<DOCNO>NCT01916707</DOCNO>
	<brief_summary>Hospitalized trauma patient frequently suffer blood clot legs lung . To minimize risk blood clot develop , patient may give blood-thinner drug enoxaparin . Until , set dose enoxaparin give patient , regardless weight . However , recent study suggest obese patient , set dose may inadequate . The purpose study evaluate whether dose enoxaparin base patient 's weight help prevent formation blood clot . The information gather study help doctor understand best way prevent blood clot future trauma patient . The potential risk participate study include minor risk blood draw ultrasound , well significant risk bleed side effect enoxaparin .</brief_summary>
	<brief_title>Weight Based Enoxaparin Trauma Patients</brief_title>
	<detailed_description />
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<criteria>18 year age old Body Weight &gt; 60 kg Admitted trauma service Intermountain Medical Center Have receive 1 standard dose enoxaparin VTE prophylaxis current hospital admission . Significant bleeding injury solid organ laceration intracranial bleed discretion attend physician Renal insufficiency ( GFR &lt; 30 ) Platelet count &lt; 100 thousand per cubic ml Hypersensitivity heparin prior document heparin induce thrombocytopenia ( HIT ) patient report medical record Pregnant breast feed Hemorrhagic stroke proceed 3 month abnormal baseline coagulation characterize INR &gt; 1.4 , obtain discretion treat clinician Required therapeutic anticoagulation atrial fibrillation , prior VTE , mechanical heart valve Treatment concomitant antiplatelet agent aspirin 326 mg daily Subjects life expectancy le 1 month Subjects hospitalize 72 hour prior randomization .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>trauma</keyword>
	<keyword>enoxaparin</keyword>
	<keyword>weight base</keyword>
	<keyword>prophylaxis</keyword>
</DOC>